QuantLogix ← MRK scorecard
📅 MRK Earnings Preview
Merck & Co., Inc.
Next report (est.)
11/30/2026
Countdown
79 days
EPS growth YoY
-130.7%
Revenue growth YoY
+5.1%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/07/2026 ±2.8% +0.2% over-priced
05/04/2026 ±3.0% +0.8% over-priced
11/05/2025 ±3.4% +0.6% over-priced
08/05/2025 ±4.3% +1.2% over-priced
05/02/2025 ±3.3% -0.1% over-priced
11/06/2024 ±2.5% -0.9% over-priced
08/05/2024 ±5.0% -2.5% over-priced
05/03/2024 ±1.6% -0.6% over-priced
Across these reports, options implied an average ±3.3% move vs an actual average of 0.9% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $-0.54 $16.6B $-1.3B
Q1 FY2026 $-1.72 $16.3B $-4.2B
Q4 FY2025 $1.20 $16.4B $3.0B
Q3 FY2025 $2.32 $17.3B $5.8B
Analyst posture
Buy / Strong Buy
26
Hold
10
Sell
0
Stable: +0 net change 30d
Live 5-factor engine read: Neutral · 51/100 Full scorecard →
Get alerted before every MRK report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on MRK before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Merck & Co., Inc. (MRK) reports in 79 days, with the next report estimated for 11/30/2026. Across the last 8 reports, options priced an average ±3.3% earnings move while the stock actually moved 0.9% on average — the market has systematically over-priced MRK's earnings risk. Fundamentals into the print: EPS down 130.7% year-over-year, revenue up 5.1%. QuantLogix's live 5-factor engine currently reads MRK as a neutral at 51/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →